Acquisition of Assets and the Connected Transaction 2. Information Memorandum regarding the offering of the newly issued ordinary shares to specific investors (Private Placement) 3. Capital Increase Report Form
should be adequate and unambiguous for the investors to understand the investment policy, securities or assets or contract in which the fund intends to invest, all risks relating to the investment, type of
the mutual fund scheme should be adequate and unambiguous for the investors to understand the investment policy, securities or assets or contract in which the fund intends to invest, all risks relating
Acquisition of Assets and the Connected Transaction 2. Information Memorandum regarding the offering of the newly issued ordinary shares to specific investors (Private Placement) 3. Capital Increase Report Form
Black Galingale, and new products like Peptein-Plus and Shark Natural Energy. Personal care segment showed outstanding growth of 20.9% YoY mainly from successful new product launches, while international
beverage were somewhat outstanding. Currently, the Company is expanding the new coffee brand into more office locations and is exploring opportunities to add Mikka corner to some of the existing After You
by fully depreciated 3G assets. Economic recovery and our 5G strategy led AIS to launch more marketing activities and campaigns, resulting in increased marketing expenses during 1H22 by 16% YoY and
Total assets as of the ending quarter declined -3.0% to Bt345,369mn, compared to the end of 2021. Current assets were at Bt37,885mn, which increased 6.5% from higher handset inventories. Total non-current
Total assets as of the ending quarter declined -3.0% to Bt345,369mn, compared to the end of 2021. Current assets were at Bt37,885mn, which increased 6.5% from higher handset inventories. Total non-current
Total assets as of the ending quarter declined -3.0% to Bt345,369mn, compared to the end of 2021. Current assets were at Bt37,885mn, which increased 6.5% from higher handset inventories. Total non-current